- Home
- TROX vs ORGO Comparison
TROX vs ORGO Comparison
Compare TROX & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROX
- ORGO
- Stock Information
- Founded
- TROX 2018
- ORGO 1985
- Country
- TROX United States
- ORGO United States
- Employees
- TROX N/A
- ORGO N/A
- Industry
- TROX Major Chemicals
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- TROX Industrials
- ORGO Health Care
- Exchange
- TROX Nasdaq
- ORGO Nasdaq
- Market Cap
- TROX 653.1M
- ORGO 620.3M
- IPO Year
- TROX 2005
- ORGO N/A
- Fundamental
- Price
- TROX $4.30
- ORGO $5.15
- Analyst Decision
- TROX Buy
- ORGO Buy
- Analyst Count
- TROX 8
- ORGO 2
- Target Price
- TROX $5.64
- ORGO $7.50
- AVG Volume (30 Days)
- TROX 4.8M
- ORGO 640.0K
- Earning Date
- TROX 10-23-2025
- ORGO 08-07-2025
- Dividend Yield
- TROX 4.66%
- ORGO N/A
- EPS Growth
- TROX N/A
- ORGO N/A
- EPS
- TROX N/A
- ORGO N/A
- Revenue
- TROX $2,949,000,000.00
- ORGO $429,531,000.00
- Revenue This Year
- TROX N/A
- ORGO $2.57
- Revenue Next Year
- TROX $4.56
- ORGO $9.80
- P/E Ratio
- TROX N/A
- ORGO N/A
- Revenue Growth
- TROX 0.24
- ORGO N/A
- 52 Week Low
- TROX $2.95
- ORGO $2.46
- 52 Week High
- TROX $15.07
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- TROX 52.26
- ORGO 63.07
- Support Level
- TROX $4.04
- ORGO $4.41
- Resistance Level
- TROX $4.35
- ORGO $4.95
- Average True Range (ATR)
- TROX 0.29
- ORGO 0.24
- MACD
- TROX 0.13
- ORGO 0.03
- Stochastic Oscillator
- TROX 95.38
- ORGO 97.37
About TROX Tronox Holdings plc (UK)
Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.